People
Jennifer Stewart is a senior associate in King & Spalding’s Mass Tort and Toxic Tort and Product Liability practices. Jennifer defends Fortune 100 and other large companies in a wide range of complex litigation matters, including pharmaceutical and other product liability, toxic tort and commercial cases. She also has significant deposition, motion, case management and trial experience.
King & Spalding's Tort Litigation practice was selected by The American Lawyer in 2012 as one of the top three in the United States, and the Product Liability practice was selected by Law360 in 2014 as one of the top five in the United States.
Prior to joining King & Spalding, Jennifer spent several years as an associate at a business litigation firm in New York City, where she was a member of litigation and trial teams, defending Fortune 100 companies in product liability and toxic tort cases.
Jennifer obtained her Juris Doctor from The Catholic University of America, Columbus School of Law. In law school, she served as the senior note and comment editor for the Commlaw Conspectus: Journal of Communications Law and Policy.
J.D., Columbus School of Law
B.A., Boston University, cum laude
California
New Jersey
New York
U.S. District Court for the Central District of California
U.S. District Court for the District of New Jersey
U.S. District Court for the Southern District of New York
December 8, 2022
King & Spalding Promotes 24 New Partners and 17 Counsel Across 15 Cities
December 8, 2022
K&S elects 24 new partners and promotes 17 counsel across 15 cities
Represents AstraZeneca Pharmaceuticals LP in coordinated California state court product liability cases related to treatment with Crestor®.
Defends Bristol-Myers Squibb Company and AstraZeneca Pharmaceuticals LP in litigation in state and federal courts related to treatment with Onglyza®, a type 2 diabetes therapy.
Represented Fortune 100 companies in products matters involving alleged harm as a result of exposure to asbestos. Jennifer has experience in handling all aspects of these cases and, as such, has secured dismissals or favorable settlements for her clients.
See more
December 8, 2022
King & Spalding Promotes 24 New Partners and 17 Counsel Across 15 Cities
December 8, 2022
K&S elects 24 new partners and promotes 17 counsel across 15 cities
Represents AstraZeneca Pharmaceuticals LP in coordinated California state court product liability cases related to treatment with Crestor®.
Defends Bristol-Myers Squibb Company and AstraZeneca Pharmaceuticals LP in litigation in state and federal courts related to treatment with Onglyza®, a type 2 diabetes therapy.
Represented Fortune 100 companies in products matters involving alleged harm as a result of exposure to asbestos. Jennifer has experience in handling all aspects of these cases and, as such, has secured dismissals or favorable settlements for her clients.
See more
December 8, 2022
King & Spalding Promotes 24 New Partners and 17 Counsel Across 15 Cities
December 8, 2022
K&S elects 24 new partners and promotes 17 counsel across 15 cities
J.D., Columbus School of Law
B.A., Boston University, cum laude
California
New Jersey
New York
U.S. District Court for the Central District of California
U.S. District Court for the District of New Jersey
U.S. District Court for the Southern District of New York